Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 299
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | ||
| NCT00004209 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | ||
| NCT00664781 | Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer | ||
| NCT01836692 | Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study | ||
| NCT02741856 | Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation | ||
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations | ||
| NCT05541601 | Prospective Cohort for Early Detection of Liver Cancer | ||
| NCT05255653 | Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features | ||
| NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | ||
| NCT00532194 | An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer | ||
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT05047107 | Biology and Genetics of Smouldering Myeloma | ||
| NCT00974792 | Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma | ||
| NCT00641095 | Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma | ||
| NCT03096054 | A CR-UK Phase I Trial of LY3143921 | ||
| NCT01140737 | A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas | ||
| NCT04455815 | A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) | ||
| NCT01584258 | Prostate Advances in Comparative Evidence | ||
| NCT01941849 | Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma | ||
| NCT05574647 | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer | ||
| NCT00509561 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) | ||
| NCT03327662 | Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer | ||
| NCT06086574 | Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer | ||
| NCT05877352 | Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial | ||
| NCT02272478 | Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations | ||
| NCT02223923 | Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours | ||
| NCT02417662 | Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT02071940 | PLX3397 KIT in Acral aNd mucOsal Melanoma | ||
| NCT00900289 | Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | ||
| NCT03797443 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT02540928 | AMG 319 in HPV Positive and Negative HNSCC | ||
| NCT00032175 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT02583542 | A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | ||
| NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | ||
| NCT00758056 | Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | ||
| NCT05097625 | Head and Neck Early Relapse Detection Study (HERD) | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT04060589 | ReIMAGINE Prostate Cancer Risk | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer | ||
| NCT04648033 | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | ||
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT06632236 | 5G-EMERALD: Amivantamab in Malignant Brain Tumours | ||
| NCT04868227 | Scottish Vitamin D Intervention Study | ||
| NCT06529718 | Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients |
